OpportunityTitle: Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
AdditionalInformationOnEligibility: Higher Education Institutions    Public/State Controlled Institutions of Higher Education  Private Institutions of Higher Education  Nonprofits Other Than Institutions of Higher Education    Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)  Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)  For-Profit Organizations    Small Businesses  For-Profit Organizations (Other than Small Businesses)  Local Governments    State Governments  County Governments  City or Township Governments  Special District Governments  Indian/Native American Tribal Governments (Federally Recognized)  Indian/Native American Tribal Governments (Other than Federally Recognized)  Federal Governments     U.S. Territory or Possession    Other    Independent School Districts  Public Housing Authorities/Indian Housing Authorities  Native American Tribal Organizations (other than Federally recognized tribal governments)  Faith-based or Community-based Organizations  Regional Organizations  Non-domestic (non-U.S.) Entities (Foreign Organizations)  Foreign Organizations  Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.    Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.    Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Description: The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
GrantorContactEmailDescription: Business e-mail address